Hexarelin vs Ipamorelin
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context.
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context.
PubMed paper counts, ClinicalTrials.gov listings, and regulatory context—aggregated from public databases.
GH release
A potent GHRP-class peptide studied for GH release and, in preclinical work, heart tissue—popular in secretagogue stacks.
Hexarelin stimulates GH via ghrelin receptors and was investigated for cardiac effects in animal models. It desensitizes faster than some GHRPs with daily use. Not approved for human performance or cosmetic use; WADA pro…
GH release
A selective growth-hormone secretagogue peptide—stimulates GH with less appetite spike than older GHRPs.
Ipamorelin binds ghrelin receptors and triggers pituitary GH release without strongly raising cortisol or prolactin. Clinics pair it with CJC-1295 for anti-aging and body-composition goals. Not FDA-approved for OTC use; …
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context. Hexarelin is categorized as GH release; Ipamorelin as GH release. Hexarelin: A potent GHRP-class peptide studied for GH release and, in preclinical work, heart tissue—popular in secretagogue stacks. Ipamorelin: A selective growth-hormone secretagogue peptide—stimulates GH with less appetite spike than older GHRPs.
No. They are different molecules with distinct names on labels and in research databases. Always match the full INCI or drug name—not a nickname on the front of the package.
Neither page is medical or anti-doping advice. Research peptides discussed in fitness communities may be prohibited in tested sport or unavailable as OTC supplements. Verify WADA lists and talk to a clinician.